Annual Report filed on Form 20-F with SEC

Prana Biotechnology Limited. (ASX:PBT / NASDAQ: PRAN), today announced it has filed its Annual Report on Form 20-F containing audited consolidated financial statements for the year ended June 30, 2016 with the US Securities and Exchange Commission.

The annual report is available on the Prana website (alterity-therapeutics.adrianbeyerle.com).  Shareholders may receive a hard copy of the annual report free of charge upon request.

Contacts:

Investor Relations                                                       

Rebecca Wilson                                                            

E: rwilson@buchanwe.com.au                                  

Tp: +61 3 9866 4722